Kalos Management, Inc. - ACADIA PHARMACEUTICALS INC ownership

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 191 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.85 and the average weighting 0.1%.

Quarter-by-quarter ownership
Kalos Management, Inc. ownership history of ACADIA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$244,000
-44.7%
17,075
-6.3%
0.33%
+8.6%
Q1 2022$441,000
+29.7%
18,225
-7.4%
0.30%
+228.3%
Q4 2021$340,000
+5.9%
19,689
+6.0%
0.09%
+1.1%
Q3 2021$321,000
-25.9%
18,575
-0.5%
0.09%
-48.3%
Q2 2021$433,000
-5.9%
18,6750.0%0.18%
+23.1%
Q1 2021$460,000
-54.5%
18,675
-1.5%
0.14%
-66.9%
Q4 2020$1,012,000
+24.6%
18,950
-2.6%
0.43%
+19.3%
Q3 2020$812,000
-13.2%
19,450
+0.5%
0.36%
-8.1%
Q2 2020$935,000
+39.1%
19,350
+22.9%
0.39%
+31.3%
Q1 2020$672,000
-15.5%
15,750
-16.0%
0.30%
+3.4%
Q4 2019$795,000
+16.9%
18,7500.0%0.29%
+7.0%
Q3 2019$680,000
+35.7%
18,7500.0%0.27%
+18.9%
Q2 2019$501,000
+34.3%
18,750
+34.7%
0.23%
-5.4%
Q1 2019$373,000
-11.2%
13,921
-30.6%
0.24%
+17.6%
Q4 2018$420,000
+7.1%
20,050
+4.2%
0.20%
-2.4%
Q3 2018$392,000
-5.8%
19,250
+7.8%
0.21%
+11.1%
Q2 2018$416,000
-50.0%
17,850
-50.0%
0.19%
-23.2%
Q1 2018$832,000
+49.1%
35,700
+91.4%
0.25%
-6.1%
Q4 2017$558,000
-2.1%
18,650
+23.1%
0.26%
-28.6%
Q3 2017$570,000
+56.6%
15,150
+42.9%
0.37%
+42.2%
Q1 2017$364,000
+19.0%
10,6000.0%0.26%
+4.5%
Q4 2016$306,000
+8.5%
10,600
+19.8%
0.25%
+2.9%
Q3 2016$282,000
+22.6%
8,850
+24.6%
0.24%
+34.8%
Q2 2016$230,0007,1000.18%
Other shareholders
ACADIA PHARMACEUTICALS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Baker Brothers Advisors 28,439,114$590,396,0003.89%
GREAT POINT PARTNERS LLC 1,196,098$24,831,0003.87%
EMORY UNIVERSITY 196,601$4,081,0002.67%
Ghost Tree Capital, LLC 500,000$10,380,0002.21%
Ghost Tree Capital, LLC 500,000$10,380,0002.21%
NEXTHERA CAPITAL LP 500,000$10,380,0001.99%
Palo Alto Investors LP 1,684,180$34,964,0001.41%
Opus Point Partners Management, LLC 20,828$432,0001.03%
Opaleye Management Inc. 195,000$4,048,0001.03%
GARRISON BRADFORD & ASSOCIATES INC 48,500$1,007,0000.81%
View complete list of ACADIA PHARMACEUTICALS INC shareholders